CASI Pharmaceuticals, Inc. (CASIF)
Develops cancer drugs and cell therapies for patients in China and the U.S.
$0.13+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-90.0%
The outlook
CASI trades near its 52-week low at $0.13, sitting well below both its 50- and 200-day moving averages. Analyst coverage appears thin or absent. The overall sentiment leans bearish, with the stock positioned at the lower end of its recent trading range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Market cap
$2.6M
52-wk high
$3.09
52-wk low
$0.05
50-day avg
$0.14
200-day avg
$0.61
Trailing P/E
—